Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 12 - 08 symbols : Snynf save search
Biosimilars market size to increase by USD 42,227.12 million: Europe to contribute 46% of market growth - Technavio
Published: 2022-12-08 (Crawled : 00:00) - prnewswire.com
SNYNF | $92.9 -2.18% 880
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.55%
H: 0.39%
C: 0.39%
VTRS | $11.32 -0.09% -0.09% 4.4M
|
Health Technology
|
| O: 0.0%
H: 0.82%
C: -1.64%
NVS | $94.41 0.95% 0.0% 1.4M
|
Health Technology
|
| O: 0.24%
H: 0.32%
C: -0.93%
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: 0.46%
H: 0.59%
C: -2.22%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: -0.15%
H: 0.0%
C: 0.0%
BIIB | $196.76 -0.72% -0.72% 1.2M
|
Health Technology
|
| O: 0.0%
H: 1.34%
C: -1.29%
AMGN | $265.505 -0.66% -0.67% 1.7M
|
Health Technology
|
| O: -0.48%
H: 0.35%
C: -1.95%
europe growth market
Alnylam Submits Supplemental New Drug Application (sNDA) to U.S. Food and Drug Administration (FDA) for ONPATTRO® (patisiran) for the Treatment of the Cardiomyopathy of ATTR Amyloidosis
Published: 2022-12-08 (Crawled : 22:00) - biospace.com/
SNYNF | $92.9 -2.18% 880
|
Health Technology
|
| O: 0.5%
H: 0.16%
C: 0.16%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: -1.32%
H: 0.0%
C: 0.0%
ALNY | $147.775 -0.49% -0.49% 490K
|
Health Technology
|
| O: 0.43%
H: 3.16%
C: 2.44%
onpattro treatment drug application food
COALITION TO STOP FLU APPLAUDS INTRODUCTION OF LEGISLATION TO BETTER PROTECT AMERICA FROM SEASONAL AND PANDEMIC INFLUENZA
Published: 2022-12-08 (Crawled : 22:00) - prnewswire.com
SNYNF | $92.9 -2.18% 880
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: -0.15%
H: 0.0%
C: 0.0%
america influenza
Sanofi Backs Out of Revolution Partnership in Latest Cancer Cull
Published: 2022-12-08 (Crawled : 16:00) - biospace.com/
SNYNF | $92.9 -2.18% 880
|
Health Technology
|
| O: 0.5%
H: 0.16%
C: 0.16%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: -1.32%
H: 0.0%
C: 0.0%
RVMD S | $35.58 -1.36% -1.38% 1.1M
|
Health Technology
|
| O: 1.41%
H: 1.22%
C: 1.06%
partnership cancer sanofi
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 Years
Published: 2022-12-08 (Crawled : 16:00) - globenewswire.com
FNCTF | $11.128 -20.84% 580
|
Communications
|
| O: -0.76%
H: 0.0%
C: 0.0%
SNYNF | $92.9 -2.18% 880
|
Health Technology
|
| O: 0.5%
H: 0.16%
C: 0.16%
PFE A | $25.91 0.19% -0.04% 34M
|
Health Technology
|
| O: -0.12%
H: 3.36%
C: 3.19%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: -1.32%
H: 0.0%
C: 0.0%
BNTX | $87.88 1.62% 1.59% 750K
|
Health Technology
|
| O: 0.37%
H: 5.31%
C: 5.26%
covid-19 fda children vaccine authorization
Wren Taps Vertex Veteran Executives and Other Leaders to Advance First-in-Class Small-Molecule Drugs into Clinical Testing for Neurodegenerative Diseases
Published: 2022-12-08 (Crawled : 15:20) - biospace.com/
SNYNF | $92.9 -2.18% 880
|
Health Technology
|
| O: 0.5%
H: 0.16%
C: 0.16%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: -1.32%
H: 0.0%
C: 0.0%
neurodegenerative
LISCure's Phase 2 Drug Candidate Granted Orphan Drug Designation (ODD) from US FDA
Published: 2022-12-08 (Crawled : 14:20) - prnewswire.com
SNYNF | $92.9 -2.18% 880
|
Health Technology
|
| O: 0.5%
H: 0.16%
C: 0.16%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: -1.32%
H: 0.0%
C: 0.0%
fda designation drug candidate granted phase 2
CANCER RESEARCH INSTITUTE VIRTUAL IMMUNOTHERAPY PATIENT SUMMIT IS NOW AVAILABLE FREE, ON-DEMAND
Published: 2022-12-08 (Crawled : 12:20) - prnewswire.com
SNYNF | $92.9 -2.18% 880
|
Health Technology
|
| O: 0.5%
H: 0.16%
C: 0.16%
LLY | $750.77 -0.12% 0.0% 2.3M
|
Health Technology
|
| O: 0.35%
H: 0.0%
C: -0.39%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: -1.32%
H: 0.0%
C: 0.0%
REGN | $898.33 -0.7% -0.71% 650K
|
Health Technology
|
| O: -0.81%
H: 2.76%
C: 0.97%
research immunotherapy cancer
Lung cancer therapeutics market size to grow by USD 10,204.33 million: High prevalence of lung cancer remains key growth driver - Technavio
Published: 2022-12-08 (Crawled : 08:00) - prnewswire.com
GLAXF | $20.07 -14.18% 1K
|
Health Technology
|
| O: 1.92%
H: 0.0%
C: 0.0%
SNYNF | $92.9 -2.18% 880
|
Health Technology
|
| O: 0.5%
H: 0.16%
C: 0.16%
AZNCF | $138.88 -4.19% 960
|
Health Technology
|
| O: 2.24%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
ALPMY | $9.55 -1.11% 300K
|
Manufacturing
|
| O: 1.24%
H: 0.97%
C: 0.19%
NVS | $94.41 0.95% 0.0% 1.4M
|
Health Technology
|
| O: -1.17%
H: 1.09%
C: 1.01%
GSK | $40.5 -0.39% -0.03% 2.8M
|
Health Technology
|
| O: -1.41%
H: 1.75%
C: 0.66%
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: 0.0%
H: 0.5%
C: 0.36%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: -1.32%
H: 0.0%
C: 0.0%
AZN | $68.75 -0.26% -0.26% 7.6M
|
Health Technology
|
| O: 0.13%
H: 0.76%
C: 0.33%
AMGN | $265.505 -0.66% -0.67% 1.7M
|
Health Technology
|
| O: 0.26%
H: 0.03%
C: -0.33%
lung therapeutics cancer growth market
Gainers vs Losers
| 49% | 51% |
Top 10 Gainers
KAVL | $6.275 135.02% 57.45% 44M
|
Wholesale Trade
PXMD | $0.7375 79.09% 44.16% 4.5M
|
Health Technology
DYNT | $0.371 -5.12% 43.09% 3.3M
|
Health Technology
LGVN P 3 d | $2.94 73.96% 42.52% 57M
|
HUBC | $1.94 49.23% 32.99% 73M
|
n/a
SPCB | $0.4044 46.52% 31.75% 130M
|
Electronic Technology
ONVO | $1.34 32.66% 24.62% 54M
|
Health Technology
OMQS | $0.6869 32.1% 24.3% 3.6M
|
Professional, Scientific, and T...
SNPO | $10.555 29.67% 22.88% 4M
|
AMBI | $3.72 -26.77% 21.77% 9.8K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.